ImmuCell
ICCC
27 hedge funds and large institutions have $5.79M invested in ImmuCell in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 27 → 27 (0)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
0.07% less ownership
Funds ownership: 13.53% → 13.46% (-0.07%)
7% less capital invested
Capital invested by funds: $6.21M → $5.79M (-$418K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$70.8K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$22.1K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$9.74K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$7.29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
-$62.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$26.1K |
| 3 |
Renaissance Technologies
New York
|
-$15.4K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$10.2K |
| 5 |
BlackRock
New York
|
-$1.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $3 | – | – | – |
|
|
CAL
27
Capital Advisors Ltd
Shaker Heights,
Ohio
| – | -$10 | -2 | -2% |
|
ICCC Hedge Fund Activity: Q1 2025 in Review
27 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2025, worth a combined $5.79M — down 6.7% from $6.21M a quarter earlier.
Fund positioning in ICCC was balanced in Q1 2025: 0 funds opened new positions, 0 closed out, 7 added to existing stakes and 7 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $70.8K. The largest seller was Mesirow Financial Investment Management, cutting an estimated $62.5K.
- 27 institutional investors held ImmuCell (ICCC) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $5.79M of ImmuCell stock for Q1 2025, down 6.7% quarter-over-quarter.
- 0 funds opened new ImmuCell positions in Q1 2025 and 0 closed out.
- The largest ImmuCell buyer in Q1 2025 was Morgan Stanley, an estimated $70.8K added.
- The largest ImmuCell seller in Q1 2025 was Mesirow Financial Investment Management, an estimated $62.5K sold.
Based on aggregated 13F filings for Q1 2025.